3 blue chip ASX stocks with over 19% returns last year

Investors generally buy blue chip stocks to reduce investment risk, as these are owned by companies with stable cash flows and extensive operations. These stocks are known to perform better during market uncertainty compared to their peers. Blue chip stocks have historically outperformed the ASX 200 in terms of returns.

(However, one must do extensive research before exposing oneself, as the sinusoidal trends in the market are evident)

On that note, let’s discuss three blue-chip ASX-listed stocks that have returned over 19% in the past year:


ResMed is a medical device manufacturing company. The company is focused on the treatment of sleep and has a portfolio of products that improve the lives of people suffering from conditions such as sleep apnea.

The healthcare company’s stock has returned more than 36% to its shareholders over the past year. However, its share price is down nearly 8% year-to-date (YTD).

For the quarter ending December 31, 2021, ResMed reported a 12% increase in revenue. Net income jumped 12% compared to the previous corresponding period. The company seeks to improve the lives of 250 million people by 2025 through its therapies and digital services.

Goodman Group Ltd. (ASX: GMG)

Goodman Group specializes in corporate real estate and industrial, development and international fund management activities.

Shares of the real estate company have returned more than 24% to its shareholders over the past year. However, the stock price is down more than 18% since the start of the year.

For the six months ending December 31, 2021, Goodman reported a 28% increase in operating profit to A$786.2 million. While net property income rose 3.4%, assets under management (AUM) jumped 32% to A$68.2 billion.

Commonwealth Bank of Australia (ASX: ABC)

Commonwealth Bank of Australia, or CommBank, is an Australian multinational bank with businesses in New Zealand, Asia, the United States and the United Kingdom.

Shares of Australia’s largest bank are up more than 19% in the past year and more than 1% year-to-date.

Commonwealth Bank reported a more than 20% rise in earnings in 1HFY22. The Australian bank also announced its A$2 billion buyout plans in its financial results for the year ending December 31, 2021.

RELATED ARTICLE: Summary of products for the week that was

RELATED ARTICLE: COVID-19: What’s the buzz around the fourth encore?

RELATED ARTICLE: WTC, XRO and CPU: How These Three ASX Tech Stocks Fared Today

Comments are closed.